CN Stock MarketDetailed Quotes

688443 Chongqing Genrix Biopharmaceutical

Watchlist
  • 26.54
  • -1.69-5.99%
Market Closed Nov 15 15:00 CST
9.73BMarket Cap-12483P/E (TTM)

Chongqing Genrix Biopharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
8,875.43%12.49M
-90.47%12.66K
-93.67%6.33K
154.92%1.21M
-69.59%139.13K
-70.57%132.8K
1,479.93%100.01K
-98.79%475.24K
148.83%457.59K
451.26K
Operating revenue
8,875.43%12.49M
-90.47%12.66K
-93.67%6.33K
154.92%1.21M
-69.59%139.13K
-70.57%132.8K
1,479.93%100.01K
-98.79%475.24K
148.83%457.59K
--451.26K
Total operating cost
-2.44%561.97M
-7.28%363.52M
-18.53%164.59M
26.40%815.12M
25.71%576M
48.51%392.06M
143.25%202.04M
72.72%644.89M
458.21M
264M
Operating cost
2,294.25%2.42M
-95.59%4.36K
-97.73%2.18K
39.78%739.8K
-80.66%101.06K
-80.42%98.88K
4,298.32%95.92K
-97.27%529.27K
--522.43K
--505.01K
Operating tax surcharges
22.05%2.05M
20.32%1.35M
21.76%675.29K
-10.17%2.56M
-9.62%1.68M
-13.53%1.12M
-23.73%554.6K
7.31%2.85M
--1.86M
--1.3M
Operating expense
3,870.00%69.21M
12,257.38%36.97M
--12.4M
--10.43M
--1.74M
--299.17K
----
----
----
----
Administration expense
-21.93%94.44M
-26.45%61.88M
-39.59%27.9M
6.34%163.36M
13.51%120.97M
37.88%84.14M
267.84%46.18M
534.37%153.62M
--106.57M
--61.02M
Financial expense
-370.29%-44.1M
-213.99%-20.24M
-172.30%-6.31M
-47.18%17.64M
-33.92%16.31M
13.77%17.76M
21.39%8.73M
5.06%33.4M
--24.69M
--15.61M
-Interest expense (Financial expense)
-25.68%20.61M
-28.23%13.12M
-20.60%7.03M
6.84%34.99M
16.86%27.73M
20.39%18.28M
21.93%8.86M
1.01%32.75M
--23.73M
--15.19M
-Interest Income (Financial expense)
-461.35%-64.72M
-5,182.42%-33.37M
-22,497.04%-13.35M
-10,742.26%-17.46M
-10,853.62%-11.53M
-824.11%-631.72K
-58.13%-59.06K
60.41%-161.07K
---105.25K
---68.36K
Research and development
0.63%437.94M
-1.76%283.55M
-11.29%129.93M
36.50%620.4M
34.08%435.19M
55.55%288.65M
134.05%146.47M
53.90%454.49M
--324.57M
--185.56M
Credit Impairment Loss
---727.13K
57.66%-633.03
94.39%-316.51
----
----
94.13%-1.5K
-1,534.23%-5.64K
----
---1.04K
---25.47K
Asset Impairment Loss
-110.63%-107.72K
-110.46%-86.47K
90.16%-60.6K
178.40%975.29K
201.31%1.01M
1,093.27%826.31K
-1,034.18%-615.67K
-364.69%-1.24M
---1M
---83.19K
Other net revenue
Fair value change income
-38.67%1.09M
----
----
-72.80%1.94M
-70.75%1.78M
-60.91%1.56M
-53.52%898.02K
73.68%7.14M
--6.07M
--3.98M
Invest income
--11.12K
--11.12K
--11.12K
----
----
----
----
3,324.24%719.73K
--719.73K
--719.73K
Asset deal income
---1.75K
---1.75K
----
----
----
----
----
--475.24
--475.24
----
Other revenue
-29.54%3.41M
18.03%1.65M
25.65%874.47K
-84.25%9.68M
120.18%4.84M
3.51%1.4M
0.16%695.96K
614.97%61.44M
--2.2M
--1.35M
Operating profit
3.95%-545.81M
6.76%-361.93M
18.51%-163.76M
-39.03%-801.32M
-26.34%-568.23M
-50.68%-388.15M
-149.71%-200.96M
-79.16%-576.36M
-93.08%-449.77M
-257.6M
Add:Non operating Income
----
----
----
3,058,314.12%26K
----
----
----
-99.85%0.85
--0.85
--0.85
Less:Non operating expense
5,647.06%535.97K
-11.79%4.62K
44.73%6.16K
1,517.98%29.41K
438.16%9.33K
212.49%5.24K
--4.26K
-99.58%1.82K
--1.73K
--1.68K
Total profit
3.85%-546.34M
6.76%-361.93M
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
-92.73%-449.77M
-257.61M
Net profit
FPtoL-546.34M
FPtoL-361.93M
FPtoL-163.77M
FPtoL-801.32M
FPtoL-568.24M
FPtoL-388.15M
FPtoL-200.97M
FPtoL-576.37M
FPtoL-449.77M
-257.61M
Net profit from continuing operation
3.85%-546.34M
6.76%-361.93M
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
---449.77M
---257.61M
Net profit of parent company owners
3.85%-546.34M
6.76%-361.93M
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
-92.73%-449.77M
---257.61M
Earning per share
Basic earning per share
19.89%-1.49
29.79%-0.99
38.36%-0.45
-19.05%-2.5
-13.41%-1.86
-50.00%-1.41
-151.72%-0.73
-79.49%-2.1
---1.64
---0.94
Diluted earning per share
19.89%-1.49
29.79%-0.99
38.36%-0.45
-19.05%-2.5
-13.41%-1.86
-50.00%-1.41
-151.72%-0.73
-79.49%-2.1
---1.64
---0.94
Other composite income
Total composite income
3.85%-546.34M
6.76%-361.93M
18.51%-163.77M
-39.03%-801.32M
-26.34%-568.24M
-50.68%-388.15M
-149.72%-200.97M
-78.92%-576.37M
-449.77M
-257.61M
Total composite income of parent company owners
3.85%-546.34M
6.76%-361.93M
----
----
-26.34%-568.24M
-50.68%-388.15M
----
----
---449.77M
---257.61M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
--
--
--
Auditor
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 8,875.43%12.49M-90.47%12.66K-93.67%6.33K154.92%1.21M-69.59%139.13K-70.57%132.8K1,479.93%100.01K-98.79%475.24K148.83%457.59K451.26K
Operating revenue 8,875.43%12.49M-90.47%12.66K-93.67%6.33K154.92%1.21M-69.59%139.13K-70.57%132.8K1,479.93%100.01K-98.79%475.24K148.83%457.59K--451.26K
Total operating cost -2.44%561.97M-7.28%363.52M-18.53%164.59M26.40%815.12M25.71%576M48.51%392.06M143.25%202.04M72.72%644.89M458.21M264M
Operating cost 2,294.25%2.42M-95.59%4.36K-97.73%2.18K39.78%739.8K-80.66%101.06K-80.42%98.88K4,298.32%95.92K-97.27%529.27K--522.43K--505.01K
Operating tax surcharges 22.05%2.05M20.32%1.35M21.76%675.29K-10.17%2.56M-9.62%1.68M-13.53%1.12M-23.73%554.6K7.31%2.85M--1.86M--1.3M
Operating expense 3,870.00%69.21M12,257.38%36.97M--12.4M--10.43M--1.74M--299.17K----------------
Administration expense -21.93%94.44M-26.45%61.88M-39.59%27.9M6.34%163.36M13.51%120.97M37.88%84.14M267.84%46.18M534.37%153.62M--106.57M--61.02M
Financial expense -370.29%-44.1M-213.99%-20.24M-172.30%-6.31M-47.18%17.64M-33.92%16.31M13.77%17.76M21.39%8.73M5.06%33.4M--24.69M--15.61M
-Interest expense (Financial expense) -25.68%20.61M-28.23%13.12M-20.60%7.03M6.84%34.99M16.86%27.73M20.39%18.28M21.93%8.86M1.01%32.75M--23.73M--15.19M
-Interest Income (Financial expense) -461.35%-64.72M-5,182.42%-33.37M-22,497.04%-13.35M-10,742.26%-17.46M-10,853.62%-11.53M-824.11%-631.72K-58.13%-59.06K60.41%-161.07K---105.25K---68.36K
Research and development 0.63%437.94M-1.76%283.55M-11.29%129.93M36.50%620.4M34.08%435.19M55.55%288.65M134.05%146.47M53.90%454.49M--324.57M--185.56M
Credit Impairment Loss ---727.13K57.66%-633.0394.39%-316.51--------94.13%-1.5K-1,534.23%-5.64K-------1.04K---25.47K
Asset Impairment Loss -110.63%-107.72K-110.46%-86.47K90.16%-60.6K178.40%975.29K201.31%1.01M1,093.27%826.31K-1,034.18%-615.67K-364.69%-1.24M---1M---83.19K
Other net revenue
Fair value change income -38.67%1.09M---------72.80%1.94M-70.75%1.78M-60.91%1.56M-53.52%898.02K73.68%7.14M--6.07M--3.98M
Invest income --11.12K--11.12K--11.12K----------------3,324.24%719.73K--719.73K--719.73K
Asset deal income ---1.75K---1.75K----------------------475.24--475.24----
Other revenue -29.54%3.41M18.03%1.65M25.65%874.47K-84.25%9.68M120.18%4.84M3.51%1.4M0.16%695.96K614.97%61.44M--2.2M--1.35M
Operating profit 3.95%-545.81M6.76%-361.93M18.51%-163.76M-39.03%-801.32M-26.34%-568.23M-50.68%-388.15M-149.71%-200.96M-79.16%-576.36M-93.08%-449.77M-257.6M
Add:Non operating Income ------------3,058,314.12%26K-------------99.85%0.85--0.85--0.85
Less:Non operating expense 5,647.06%535.97K-11.79%4.62K44.73%6.16K1,517.98%29.41K438.16%9.33K212.49%5.24K--4.26K-99.58%1.82K--1.73K--1.68K
Total profit 3.85%-546.34M6.76%-361.93M18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M-92.73%-449.77M-257.61M
Net profit FPtoL-546.34MFPtoL-361.93MFPtoL-163.77MFPtoL-801.32MFPtoL-568.24MFPtoL-388.15MFPtoL-200.97MFPtoL-576.37MFPtoL-449.77M-257.61M
Net profit from continuing operation 3.85%-546.34M6.76%-361.93M18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M---449.77M---257.61M
Net profit of parent company owners 3.85%-546.34M6.76%-361.93M18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M-92.73%-449.77M---257.61M
Earning per share
Basic earning per share 19.89%-1.4929.79%-0.9938.36%-0.45-19.05%-2.5-13.41%-1.86-50.00%-1.41-151.72%-0.73-79.49%-2.1---1.64---0.94
Diluted earning per share 19.89%-1.4929.79%-0.9938.36%-0.45-19.05%-2.5-13.41%-1.86-50.00%-1.41-151.72%-0.73-79.49%-2.1---1.64---0.94
Other composite income
Total composite income 3.85%-546.34M6.76%-361.93M18.51%-163.77M-39.03%-801.32M-26.34%-568.24M-50.68%-388.15M-149.72%-200.97M-78.92%-576.37M-449.77M-257.61M
Total composite income of parent company owners 3.85%-546.34M6.76%-361.93M---------26.34%-568.24M-50.68%-388.15M-----------449.77M---257.61M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------------
Auditor ------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data